Adams Kendra — SEC insider filings
SEC reporting owner CIK 1991929. 11 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2023-09-19 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 45,173 shares, $122,487 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 45,173 shares @ $2.71 ($122,487) in C4 Therapeutics, Inc., filed 2026-11-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | 11 | — | 1 leg · 45,173 sh · $122,487 | 27 |
Insider filings — Adams Kendra
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | C4 Therapeutics, Inc. (CCCC) | Sale (S): 45,173 @ $2.71 | EDGAR |
| 2026-09-21 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 6,250 @ $0 · Tax withholding (F): 2,775 @ $3.39 | EDGAR |
| 2026-02-18 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 240,000 @ $0 · Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,863 @ $1.89 · Option exercise (M): 30,950 @ $0 · Tax withholding (F): 15,381 @ $1.89 | EDGAR |
| 2025-09-19 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 6,250 @ $0 · Tax withholding (F): 2,775 @ $3.32 | EDGAR |
| 2025-02-18 | 4 | C4 Therapeutics, Inc. (CCCC) | Tax withholding (F): 1,863 @ $3.20 · Grant/award (A): 87,100 @ $0 · Tax withholding (F): 4,559 @ $3.18 · Grant/award (A): 130,600 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 3,750 · Tax withholding (F): 1,102 @ $6.04 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | C4 Therapeutics, Inc. (CCCC) | Tax withholding (F): 1,837 @ $6.38 | EDGAR |
| 2024-09-17 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 2,250 · Tax withholding (F): 661 @ $6.36 · Option exercise (M): 2,250 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | C4 Therapeutics, Inc. (CCCC) | Disposition to issuer (D): 45,000 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | C4 Therapeutics, Inc. (CCCC) | Tax withholding (F): 1,301 @ $6.53 · Grant/award (A): 36,700 @ $0 · Grant/award (A): 165,300 (derivative) @ $0 | EDGAR |
| 2023-09-19 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 111,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1991929 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs